Bionano Genomics
BNGO

Bionano Genomics (BNGO) analyst forecast and price target

Analyst forecast

Buy

Consensus of 1 analyst rating

Buy
1
Hold
0
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$6.00 from $7.00Apr 13, 2026
HC Wainwright & Co.MaintainedBuy$7.00 from $11.00Nov 24, 2025
HC Wainwright & Co.MaintainedBuy$11.00 from $10.00Aug 18, 2025
Maxim GroupUpgradedHold → Buy$8.00May 20, 2025
HC Wainwright & Co.Initiated CoverageBuy$10.00Apr 9, 2025
ScotiabankMaintainedSector Perform$4.00 from $1.00Apr 2, 2025
Ladenburg ThalmannDowngradedBuy → NeutralNov 15, 2024
BTIGDowngradedBuy → NeutralSep 10, 2024
ScotiabankDowngradedSector Outperform → Sector Perform$1.00 from $6.00Aug 28, 2024
BTIGMaintainedBuy$2.00 from $3.00May 16, 2024
ScotiabankMaintainedSector Outperform$6.00 from $7.00Mar 7, 2024
Maxim GroupDowngradedBuy → HoldNov 13, 2023
BTIGMaintainedBuy$10.00 from $2.00Aug 10, 2023
BTIGMaintainedBuy$2.00 from $3.00May 18, 2023

Frequently asked questions

  • Is BNGO a buy, sell, or hold?

    Analysts covering Bionano Genomics currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on BNGO?

    On Apr 13, 2026, HC Wainwright & Co. maintained Bionano Genomics at Buy with a price target of $6.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.